跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
优罗华 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Polatuzumab Vedotin for Injection
Approved
生物制品
Polatuzumab Vedotin for Injection
Roche Pharma (Schweiz) AG
🇨🇳 National Medical Products Administration
Approval Date
Jan 10, 2023
Approval ID
894f57ecc00a87cc
Company
Roche Pharma (Schweiz) AG
Type
生物制品
Approval Details
Approval Id
894f57ecc00a87cc
Approval Number
国药准字SJ20230003
Generic Name
注射用维泊妥珠单抗
Generic Name En
Polatuzumab Vedotin for Injection
Trade Name
优罗华
Drug Type
生物制品
Dosage Form
注射剂
Strength
140mg/瓶
Reg Date
2023-01-10
Expired Date
2028-01-09
Company Name
Roche Pharma (Schweiz) AG
Production Company Name
BSP PHARMACEUTICALS SPA
Company Detail Path
/organization/roche-pharma-schweiz-ag
Production Company Detail Path
/organization/bsp-pharmaceuticals-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 10, 2023
Approval ID
894f57ecc00a87cc
Type
生物制品
Back to NMPA Approvals